We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Blur Group | BLUR | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
5.72 | 5.72 |
Top Posts |
---|
Posted at 07/12/2017 08:40 by j777j "In early August, company founder Philip Letts ceased to be the chief executive, with former chief commercial officer Laurence Cook taking over the reins.His pedigree looks good: he has 25 years' experience in the information and communication technology industry, having led global sales teams at industry giants Siemens, Cable & Wireless and NTL.His task is to ensure blur starts fulfilling the potential investors saw in the company when it was a stock market star in 2013, when the share price rose from around 78p to 577p." (Proactive 23rd no 2017.) |
Posted at 02/8/2017 09:39 by chesty1 Down we go zzzzz!!! What a dog stock do you really think real investors are going to look twice at this! |
Posted at 07/7/2017 08:53 by angus17 Torotrak beats that fall. Afraid the personal investors are there to be scammed. |
Posted at 23/6/2017 06:53 by dusseldorf Looks like they've fallen out with the 'white knight' investor - bear in mind he bought majority of his stock at 3.5p/share.What alternative funding sources? the company has burnt through about $40m+ in 5 years with little sight (to date) of improved cash burn - who's going to lend to them? Not here to gloat, but I hope some of you heeded my advice that any placement was always going to be at a discount and that the company is insolvent without funding. I don't think it's quite a dead duck, but the next 2 months are crucial to it's survival. |
Posted at 02/4/2017 21:42 by zico01 This could the week it kick starts the re-rating :Investor builds stake Blur’s more stable footing has also started to attract investor interest. Robert Keith, a former director of computer software company Eidos (the 'Championship Manager' people), and a major stakeholder in drug development company Silence Therapeutics PLC (LON:SLN) has been buying significant amounts of shares. Keith has recently increased his stake from 1.32 million shares to 6.84mln shares, equivalent to 14.5% of the issued share capital of the AIM-listed company. According to his profile on news agency Bloomberg, he serves as a technical consultant to several high-tech companies, so he knows the sector well. |
Posted at 13/3/2017 18:53 by deltalo Nice to see that delayed trade of £119k. A few of them have been popping up, as last week there were a £58k and a £200k buys. Big investors are starting to return. They will push this up fast. |
Posted at 10/3/2017 12:59 by deltalo This will end the day up. Next week will se investors returning as we get ever closer to finding out who the global company is and how many millions we get. Good entry price. |
Posted at 09/3/2017 12:47 by leedskier Currencycloud Secures £20M ($25M) From GV and Existing Investors to Boost Further Global Expansion9th March 2017: London and New York - Currencycloud, the world’s leading cross border payments platform today announced £20 million (US $25M) in Series D funding with a new investment from GV (formerly Google Ventures) and additional funding from the existing investors – Notion Capital, Sapphire Ventures, Rakuten FinTech Fund, and Anthemis. Total investment in the five-year-old company now stands at £44 million ($61 million). |
Posted at 09/3/2017 08:59 by dusseldorf From interim results last year (for reference the period in question is up to June 30th 2017:However, beyond the forecast period the Group will need either to substantially increase its revenues or take actions to ensure it remains sufficiently funded. As with any disruptive, evolving technology company there is always an inherent risk over the ability of the Group and Company to continue as a going concern if forecasts are not met and cash resources are not adequate. Also.. The Company will host a Capital Markets Day at the Group's offices in Q4 2016. Chaired by Philip Letts, Chief Executive Officer, the day will focus on the company's pipeline, operations and technology and will provide an opportunity for analysts and investors to meet management. Further details will be made available in due course. Does anyone know if this happened - there was no update as promised AFAIK A bit of research suggests I'm not alone in my view Steve Moore on share prophets finishes his piece on Blurs ramparoony RNS with The shares spiked to more than 18p in December before slumping back – and I consider this latest spike, on the back of a ludicrous announcement, a further selling opportunity for any holders as we head towards a bailout placing being required. |
Posted at 08/3/2017 07:56 by dusseldorf landmark2 - previous prices are irrelevant - there have been dilutions and the business model has changed. The most important thing investors need to be aware of is the company is losing £750k every 3 months (though hopefully that is improving) and runs out of cash in July. This means they need a substantial cash injection to keep moving - I think at least £5m.Any 'new' deal revenue even if received 'today' will not be shown into reported results until this time next year. The trading numbers are not sufficient for any bank facility (put simply they cannot afford capital repayments) so IMO this means only equity placement/dilution is possible - hence price manipulation. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions